Lexeo Therapeutics, Inc. · NASDAQ:LXEO
State Street Corp reported a 5.50% stake in Lexeo Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 5.50% stake in Lexeo Therapeutics, Inc., 4,354,775 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 4,354,775
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.50% | 4,354,775 |
Source
Related
- Lexeo Therapeutics, Inc.
- State Street Corp
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026